SearchDictionaryMobileLogin

Nic J G M Veeger Selected Research

Thromboembolism

07/2008Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
03/2005Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
07/2004The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

Articles by Research Topic

Disease

5Atrial Fibrillation
09/2006 - 01/2005
3Thromboembolism
07/2008 - 07/2004
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2008
1Cytomegalovirus Infections (Inclusion Disease)
01/2008
1Thrombosis (Thrombus)
12/2007
1Venous Thromboembolism
02/2007
1Pemphigus (Pemphigus Vulgaris)
05/2006
1Heart Failure
06/2005
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2004
1Pathologic Constriction (Stenosis)
07/2002

Drug/Important Bio-Agent (IBA)

1Carboxypeptidase U (TAFI)IBA
07/2008
1Factor VIII (Coagulation Factor VIII)IBA
12/2007
1Oral ContraceptivesIBA
02/2007
1Digoxin (Digitek)FDA LinkGeneric
09/2006
1Verapamil (Calan)FDA LinkGeneric
09/2006
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2006
1Flecainide (Tambocor)FDA LinkGeneric
03/2005
1Protein SIBA
03/2005
1Antiphospholipid AntibodiesIBA
07/2004

Therapy/Procedure

5Electric Countershock (Cardioversion)
09/2006 - 01/2005
1Kidney Transplantation
01/2008
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2002
1Percutaneous Coronary Transluminal Angioplasty (PTCA)
07/2002